dpp-4 inhibitor and glp-1 receptor agonist combination Dipeptidyl peptidase-4 GLP-1 receptor agonist versus DPP-4

ADA Recommendations for GLP-1 RA in T2DM Patients The GLP-1 receptor agonists, with or without metformin based on glycemic needs, are appropriate initial therapy for patients with type 2 diabetes mellitus (T2DM) with or at high risk for atherosclerotic cardiovascular disease (ASCVD)/indicators of high-risk, heart failure (HF), or chronic kidney disease (CKD)

Sonophoresis: Uses ultrasound waves to temporarily disrupt the skin barrier

Long-term follow-up after bariatric surgery in a national cohort

AdvaLife offers a proven platform for success

Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes2019